BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of 199.26 billion as of June 25, 2025. Its market cap has decreased by -25.91% in one year.

Market Cap

199.26B

Enterprise Value

186.52B

Revenue

60.30B

Ranking

n/a

PE Ratio

18.61

Stock Price

1,059.00

Market Cap Chart

Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 4.20B to 199.26B, an increase of 4,639.87%. That is a compound annual growth rate of 16.04%.

Market Cap History

Date	Market Cap	% Change
Jun 24, 2025	199.26B	-23.67%
Dec 31, 2024	261.03B	-14.99%
Dec 29, 2023	307.05B	-18.16%
Dec 30, 2022	375.17B	12.82%
Dec 31, 2021	332.53B	4.98%
Dec 31, 2020	316.75B	10.58%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	1,054.93B
Grupo Financiero Banorte	471.73B
Arca Continental	352.01B
Industrias Peñoles	193.40B
GMéxico Transportes	131.36B
FIBRA Prologis	110.02B
Fibra UNO	97.34B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	90.15B

Market Cap Rankings